
Sign up to save your podcasts
Or
Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
4.2
1212 ratings
Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
131 Listeners
287 Listeners
323 Listeners
46 Listeners
496 Listeners
37 Listeners
274 Listeners
8 Listeners
17 Listeners
19 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
22 Listeners
86 Listeners
27 Listeners
1,084 Listeners
5 Listeners
29 Listeners
15 Listeners
21 Listeners
186 Listeners
132 Listeners
5 Listeners
351 Listeners
106 Listeners
21 Listeners
2 Listeners
3 Listeners
162 Listeners
78 Listeners